Financing round-up: SpliceBio, Ada Health, LinKinVax, Nobi, Perfuze

Ireland: Perfuze, a medical device company developing next-generation catheter-based aspiration technology to treat large vessel occlusion acute ischemic stroke, has closed a €22.5m (US$25m) Series A investment round led by new investors LSP (from its Health Economics Fund 2) and Seroba Life Sciences, joined by new investor SV Health (from its Medtech Convergence Fund) and…

You must be a HMI Subscriber to view this content.

Subscribe Now »